Original Research
10.4244/EIJ-D-25-00331 • May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y, Park S-D, Lee JP, Choi SH, Kong MG, Won YS, Kim M, Lee KH, Han SH, Kwon SW, Suh J, Kang WC
open access
Research Correspondence
10.4244/EIJ-D-25-00396 • May 21, 2025
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study
Haude M, Wlodarczak A, van der Schaaf R, Torzewski J, Ferdinande B, Escaned J, Iglesias J, Bennett J, Toth G, Joner M, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Waksman R
Expert consensus
10.4244/EIJ-D-24-01126 • May 20, 2025
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women
Baron S, Chou J, Shah T, Vest A, Abbott JD, Alasnag M, Aurigemma C, Barbato E, Bellumkonda L, Bortnick A, Chieffo A, van Geuns R, Grines C, Halvorsen S, Hassager C, Kapur N, Naidu S, Ng V, Saw J, Lansky A
open access
Expert consensus
10.4244/EIJ-D-24-00876 • May 20, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
Paradies V, Masiero G, Rubboli A, van Beusekom H, Costa F, Capranzano P, Degrauwe S, Gorog D, Jorge C, Buchanan G, Alasnag M, Trabattoni D, Fraccaro C, Sibbing D, Dudek D, Vilahur G, Chieffo A, Mehran R, Capodanno D, Barbato E, Siller-Matula J
open access
Expert Review
10.4244/EIJ-D-24-00972 • May 16, 2025
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation
Goel S, Tanner R, Chan K, Khan J, Vinayak M, Lerakis S, Safi L, Khera S, Krishnamoorthy P, Kini A, Sharma S, Dangas G, Tang G
Original Research
10.4244/EIJ-D-24-00662 • May 16, 2025
Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI Registry
Giannini C, Capodanno D, Toth G, Windecker S, Schüpke S, Blackman D, Noble S, Eltchaninoff H, Fiorina C, Chieffo A, Bartorelli A, Schmidt A, De Backer O, Gilard M, Curtis E, L’Official G, Donal E, Laroche C, Prendergast B, Petronio A, the European Valve Durability TAVI Registry investigators o
Original Research
10.4244/EIJ-D-24-00973 • May 16, 2025
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial
Gitto M, Baber U, Sartori S, Vogel B, Angiolillo D, Briguori C, Cohen D, Collier T, Dudek D, Oliva A, Escaned J, Feng Y, Gibson C, Han Y, Di Muro F, Shlofmitz R, Huber K, Steg P, Sharma S, Sardella G, Kastrati A, Kaul U, Kornowski R, Kunadian V, Stefanini G, Mehta S, Dangas G, Mehran R
Showing
1
to
15
of
5350
results
